Comparison of metabolic factors by cookie test between schizophrenic patients during treatments with olanzapine or risperidone

被引：0
|
作者：
Sato, Y. [1 ]
Yasui-Furukori, N. [1 ]
Saito, M. [1 ]
Nakagami, T. [1 ]
Furukori, H. [2 ]
Kaneko, S. [1 ]
机构：
[1] Hirosaki Univ, Dept Neuropsychiat, Hirosaki, Aomori, Japan
[2] Kuroishi Akebono Hosp, Dept Neuropsychiat, Kuroishi, Aomori, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2008年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [31] Rehospitalization rates of chronic schizophrenic patients discharged on a regimen of risperidone, olanzapine or conventional antipsychotics
    Rabinowitz, J
    Lichtenberg, P
    Kaplan, Z
    Mark, M
    Nahon, D
    Davidson, M
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 275 - 275
  • [32] Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients
    Yasui-Furukori, N
    Kondo, T
    Suzuki, A
    Mihara, K
    Kaneko, S
    Otani, K
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (03): : 575 - 578
  • [33] Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol
    Markianos, M
    Hatzimanolis, J
    Lykouras, L
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (03) : 141 - 146
  • [34] Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol
    Manolis Markianos
    John Hatzimanolis
    Lefteris Lykouras
    European Archives of Psychiatry and Clinical Neuroscience, 2001, 251 : 141 - 146
  • [35] A comparison of risperidone and olanzapine for the psychotic patients with tardive dyskinesia (TD)
    Chan, HY
    Chen, CH
    Chen, JJ
    Lai, CL
    Sun, HJ
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S428 - S428
  • [36] PHARMACOLOGICAL AND DISORDER ASSOCIATED CARDIOVASCULAR CHANGES IN PATIENTS WITH PSYCHOSIS. A COMPARISON BETWEEN OLANZAPINE AND RISPERIDONE
    Dehelean, Liana
    Andor, Minodora
    Romosan, Ana Maria
    Manea, Minodora Marinela
    Romosan, Radu Stefan
    Papava, Ion
    Bredicean, Ana Cristina
    Buda, Valentina Oana
    Tomescu, Mirela Cleopatra
    FARMACIA, 2018, 66 (01) : 129 - 134
  • [37] Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients
    Chen, Chun-Hsin
    Huang, Ming-Chyi
    Lu, Mong-Liang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (05) : 516 - 517
  • [38] Prolactin levels in schizophrenic patients receiving perospirone in comparison to risperidone
    Togo, T
    Iseki, E
    Shoji, M
    Oyama, L
    Kase, A
    Uchikado, H
    Katsuse, O
    Kosaka, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 (03) : 259 - 262
  • [39] A comparison between augmentation with olanzapine and increased risperidone dose in acute schizophrenia patients showing early non-response to risperidone
    Hatta, Kotaro
    Otachi, Taro
    Sudo, Yasuhiko
    Kuga, Hironori
    Takebayashi, Hiroshi
    Hayashi, Hideaki
    Ishii, Ryusuke
    Kasuya, Masataka
    Hayakawa, Tatsuro
    Morikawa, Fumiyoshi
    Hata, Kazuya
    Nakamura, Mitsuru
    Usui, Chie
    Nakamura, Hiroyuki
    Hirata, Toyoaki
    Sawa, Yutaka
    PSYCHIATRY RESEARCH, 2012, 198 (02) : 194 - 201
  • [40] Olanzapine versus risperidone: weight gain and BMI of schizophrenic patients in a 24-week trial
    Siladji-Mladenovic, D.
    Knezevic, V.
    Ivezic, A.
    Drezgic-Vukic, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S463 - S463
12345